Werewolf Therapeutics (HOWL) Earnings Date & Reports

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

HOWL is expected to report earnings to fall 17.39% to -37 cents per share on May 07

Werewolf Therapeutics HOWL Stock Earnings Reports

Q1'25

Est.

$-0.38

Q4'24

Missed

by $0.04

Q3'24

Beat

by $0.03

Q2'24

Missed

by $0.05

Q1'24

Missed

by $0.05

The last earnings report on March 11 showed earnings per share of -46 cents, missing the estimate of -41 cents. With 201.78K shares outstanding, the current market capitalization sits at 40.21M.

View a ticker or compare two or three

Compare

HOWL